Investigation of Patterns in Clinical Trial Experiences by Patients Participating in Triple Negative Breast Cancer Clinical Trials
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 500
- 主要终点
- Number of triple negative breast cancer patients who decide to enroll in a clinical study
研究概览
简要总结
Clinical trials can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical trials, both positive and negative.
The goal is to identify the obstacles and challenges that prevent participation in Triple Negative Breast Cancer clinical trials, as well as the reasons for withdrawal or discontinuation.
The insights gained from this study will ultimately benefit those with Triple Negative Breast Cancer who may be invited to participate in clinical research in the years to come.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Crossover
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Age ≥ 18 years
- •Willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study.
- •Capable of giving signed informed consent, which includes compliance with requirements and restrictions listed in the informed consent form (ICF) and in the protocol
排除标准
- •Pregnant or lactating woman
- •Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial
- •Inability to perform regular electronic reporting
结局指标
主要结局
Number of triple negative breast cancer patients who decide to enroll in a clinical study
时间窗: 3 months
Rate of triple negative breast cancer patients who remain in a clinical study to completion
时间窗: 12 months
次要结局
未报告次要终点